Talk:Pharmaceutical industry in India
|This is the talk page for discussing improvements to the Pharmaceutical industry in India article.
This is not a forum for general discussion of the article's subject.
|This article is written in Indian English (colour, travelled, centre, analysed, defence), and some terms used in it may be different or absent from other varieties of English. According to the relevant style guide, this should not be changed without broad consensus.|
|This article is of interest to the following WikiProjects:|
|It is requested that a template-based chart or charts be included in this article to improve its quality. Useful templates may be found in Category:Chart, diagram and graph formatting and function templates. Specific illustrations, plots or diagrams can be requested at the Graphic Lab.
For more information, refer to discussion on this page and/or the listing at Wikipedia:Requested images.
The validation of the Page: Pharmaceutical industry in India
In my opinion, the author of this page has forgotten to mention Cipla as an Indian Pharmaceutical Company. According to scrips 100, Cipla ranks 60, above Lupin and Dr. Reddy's which are ranked 66 and 72 respectively. Scrip100.com — Preceding unsigned comment added by Nihar 25292 (talk • contribs) 14:58, 19 November 2012 (UTC)
I am not aware as what to do in this case. The following link (which has reference number two at the time) is broken. Thanks. --Abhijeet Safai (talk) 10:54, 23 October 2013 (UTC) The link - http://www.cci.in/pdf/surveys_reports/indian-pharmaceuticals-industry.pdf
The link: http://www.pwc.in/press-releases/its-india-calling-for-global-pharmaceutical-companies.jhtml -- Abhijeet Safai (talk) 11:00, 23 October 2013 (UTC)
- Even if these links worked they are not appropriate to cite by Wikipedia guidelines at WP:RS. Information from press releases or company reports about themselves are not the kind of articles to cite. It is better to use research papers from a third party, like from an academic journal or book written by a scholar. Blue Rasberry (talk) 11:44, 25 October 2013 (UTC)
Many many flaws in the article
I think that the article has been written by personal opinions of some people. Much of the material has no reference given. It is very painful to read one sided opinions of some people. The article does not seen neutral at all. --Abhijeet Safai (talk) 11:44, 23 October 2013 (UTC)
- Completely correct. I could help someone else work on this but I would not want to work alone to fix this. Blue Rasberry (talk) 11:44, 25 October 2013 (UTC)
"However, economic liberalisation in 90s by the former Prime Minister P.V. Narasimha Rao and the then Finance Minister, Dr. Manmohan Singh enabled the industry to become what it is today." - there is no evidence for this, I am removing the line. The growth in 90s were driven by external factors. — Preceding unsigned comment added by 188.8.131.52 (talk) 05:15, 3 January 2015 (UTC)
A new section 'Pharmaceutical policy of India' can be added
http://chemicals.nic.in/npp_circulation_latest.pdf This is the link where relevant document can be found. --Abhijeet Safai (talk) 09:03, 25 October 2013 (UTC)
References for editors interested in improving this article
http://www.ibef.org/industry/pharmaceutical-india.aspx --Abhijeet Safai (talk) 07:11, 26 October 2013 (UTC)
The comment(s) below were originally left at several discussions in past years, these subpages are now deprecated. The comments may be irrelevant or outdated; if so, please feel free to remove this section., and are posted here for posterity. Following
|== Comments by Mspraveen == Consider using citation templates to appear more in the lines of manual of style. Otherwise, the article seems to have comprehensiveness to be classed higher up on the assessment quality scale. Once this is addressed, consider seeking a re-assessment at assessment department. Mspraveen (talk) 12:17, 3 September 2008 (UTC)|
Last edited at 01:45, 1 January 2012 (UTC). Substituted at 02:49, 30 April 2016 (UTC)